论文部分内容阅读
Recent years,many Chinese pharmaceutical companies are shifting their focus from generic to innovative drugs and the importance of innovative drug R&D is fully appreciated in China.Within this context,PKUCare Pharmaceutical R&D Center,a wholly-owned subsidiary of PKU International Healthcare Group of Founder,is striving to discover and develop novel drug candidates for the treatment of a broad spectrum of diseases with a focus on oncology and cardiovascular.PKUCare Pharmaceutical R&D Center has been quickly establishing its pipeline via the internal research as well as external collaborations.In this presentation,approaches and strategies taken by PKUCare Pharmaceutical R&D Center for conducting innovative drug R&D will be discussed.